Every Form 4 that Astrana Health Inc. (ASTH) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ASTH and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ASTH filings page.
Astrana Health, Inc. CEO and President Brandon Sim reported surrendering 9,889 common shares at $37.00 per share on October 6, 2026, to offset tax withholding on restricted stock units that vested that day. His reported direct holdings afterward were 1,228,972 shares. The Sim Family Irrevocable Trust 2021 held 258,824 shares, and the Brandon Sim 2020 Irrevocable Trust held 392,816 shares; Sim disclaims beneficial ownership of those trust shares except to the extent of his pecuniary interest.
Astrana Health, Inc. director Thomas S. Lam reported surrendering 2,624 directly held shares on October 6, 2026, at $37.00 per share, to offset tax withholding on restricted stock units that vested that day. He held 463,033 shares directly afterward. Separate indirect holdings were 6,132,802 shares held by Allied Physicians of California, a Professional Medical Corporation, and 1,133,706 shares held by the Thomas and Jeanette Lam 2002 Family Trust; Lam disclaimed beneficial ownership of Allied Physicians’ shares except to the extent of his pecuniary interest.
Astrana Health, Inc. COO and CFO Chandan Basho surrendered 2,092 common shares on October 2, 2026, to offset tax-withholding obligations associated with restricted stock units that vested that day. The reported price per share was $35.88. His resulting direct position was 155,728 shares, including unvested restricted stock and restricted stock units subject to continuous employment.
Astrana Health, Inc. executive John Vong, SVP – Accounting (PAO), reported a Form 4 showing a disposition of 96 shares of common stock on September 15, 2026, to pay tax withholding obligations tied to vesting restricted stock units. After this tax-withholding transaction, he directly holds 22,330 shares, including restricted stock, shares acquired under the Employee Stock Purchase Plan, and additional restricted stock units scheduled to vest over time. No Rule 10b5-1 trading plan is reported.
Astrana Health, Inc. (ASTH) reported that CEO and President Brandon Sim surrendered 7,163 shares of common stock on September 5, 2026 to pay tax withholding obligations associated with vested restricted stock units, at a reported price of $38.47 per share. This tax-withholding disposition did not involve an open-market sale and no Rule 10b5-1 trading plan is reported. Following the transaction, he holds 1,238,861 shares directly, including unvested restricted stock and restricted stock units scheduled to vest over multiple semi-annual installments, and also has indirect interests in shares held by two irrevocable trusts, for which he disclaims beneficial ownership except to the extent of his pecuniary interest.
Astrana Health, Inc. (ASTH) reported that its COO and CFO, Basho Chandan, had 1,790 shares of common stock withheld on September 5, 2026 to pay tax liabilities associated with vested restricted stock units, at a value of $38.47 per share. After this tax-withholding disposition, he holds 157,820 shares directly, including 15,202 shares of unvested restricted stock and additional restricted stock units scheduled to vest over time, all subject to continuous employment with Astrana Health.
Astrana Health, Inc. (ASTH) reported that director Mitchell W. Kitayama disposed of shares of common stock in a transaction recorded as a disposition to the issuer. On 2026-08-31, 8,500 shares were repurchased by Astrana Health at $37.09 per share. Following this repurchase, Kitayama directly holds 24,337 shares, including 4,991 shares of restricted stock that will vest on the earlier of June 10, 2027 or the company’s 2027 annual meeting of stockholders.
Astrana Health, Inc. (ASTH) director David Schmidt reported a same-day option exercise and share disposition. He exercised 20,000 stock options for Common Stock at an exercise price of $5.00 per share, then disposed of 20,000 Common Shares to the issuer at $38.59 per share. The options were fully vested and exercisable, and following these transactions his holdings include 4,525 shares of restricted stock that vest on the earlier of June 10, 2027 or the 2027 annual meeting.
Astrana Health, Inc. reported that former officer Glenn Sobotka surrendered 11,793 shares of unvested time-based and performance-based restricted common stock in a disposition to the issuer in connection with his retirement. Following this forfeiture, he holds 2,246 shares, including 1,300 restricted shares that will vest on an accelerated basis subject to his execution of a release of claims.
Astrana Health, Inc. CEO and President Brandon Sim reported routine equity activity related to restricted stock vesting. He surrendered 1,093 shares of Common Stock at $44.51 per share to cover tax withholding obligations tied to vested restricted stock, a non-market, F-code tax-withholding disposition.
After this event, he directly holds 1,245,292 Common Stock shares, which include 34,207 unvested restricted shares and multiple tranches of restricted stock units scheduled to vest in semi-annual installments beginning in late 2026, plus 1,420 shares acquired under the Employee Stock Purchase Plan. Indirectly, trusts associated with Sim hold 392,816 and 258,824 shares, for which he disclaims beneficial ownership except for any pecuniary interest.
Schmidt David reported acquisition or exercise transactions in this Form 4 filing.
Astrana Health, Inc. director David Schmidt received a grant of 4,525 shares of restricted common stock as equity compensation. These shares were awarded at no cash cost to him under the company’s 2024 Equity Incentive Plan and will vest on the earlier of June 10, 2027 or the company’s 2027 annual meeting of stockholders. After this award, he holds a total of 36,019 common shares directly.
Mazdyasni Matthew reported acquisition or exercise transactions in this Form 4 filing.
Astrana Health director Matthew Mazdyasni received an equity grant. The Form 4 reports an award of 4,525 shares of Astrana Health common stock at no purchase price, granted under the company’s 2024 Equity Incentive Plan.
These restricted shares will vest on the earlier of June 10, 2027 or the date of Astrana Health’s 2027 annual meeting of stockholders. After this grant, Mazdyasni directly owns 39,288 shares of Astrana Health common stock, including the 4,525 unvested restricted shares.
Kitayama Mitchell W reported acquisition or exercise transactions in this Form 4 filing.
Astrana Health, Inc. director Mitchell W. Kitayama received a grant of 4,991 shares of restricted common stock as equity compensation. The award was granted at no cash cost per share under the company’s 2024 Equity Incentive Plan and will vest on the earlier of June 10, 2027 or the company’s 2027 annual meeting of stockholders. Following this grant, Kitayama directly holds a total of 32,837 shares of Astrana Health common stock, including the unvested restricted shares.
Dong Linda reported acquisition or exercise transactions in this Form 4 filing.
Astrana Health, Inc. director Linda Dong received an equity award of 4,525 shares of restricted common stock. The grant was made under the company’s 2024 Equity Incentive Plan. These restricted shares will vest on the earlier of June 10, 2027 or the company’s 2027 annual meeting of stockholders. Following this grant, Dong directly holds 97,133 shares of Astrana Health common stock, including the unvested restricted shares.
Dai, Weili reported acquisition or exercise transactions in this Form 4 filing.
Astrana Health director Weili Dai received a grant of 4,525 shares of restricted common stock under the company’s 2024 Equity Incentive Plan. These shares vest on the earlier of June 10, 2027 or the date of Astrana Health’s 2027 annual stockholders meeting, bringing Dai’s direct holdings to 18,188 shares.
Astrana Health, Inc. reported that director John Chiang acquired 4,525 shares of restricted common stock as a compensation award under the company’s 2024 Equity Incentive Plan. These restricted shares vest on the earlier of June 10, 2027 or the company’s 2027 annual stockholders’ meeting, after which he will fully own them. Following this grant, Chiang directly holds 35,373 shares of Astrana Health common stock.
Astrana Health, Inc. COO and CFO Basho Chandan reported a routine share surrender to cover taxes on vested equity. On May 16, 2026, he surrendered 8,155 shares of common stock at an indicated value of $38.26 per share to satisfy tax withholding obligations on restricted stock that vested that day.
After this tax-withholding disposition, Chandan directly owns 159,610 shares of Astrana Health common stock. This total includes 15,202 shares of unvested restricted stock scheduled to vest on May 16, 2027, as well as 15,604 restricted stock units vesting in four equal semi-annual installments beginning October 2, 2026 and 20,027 restricted stock units vesting in six equal semi-annual installments beginning September 5, 2026, all subject to continued employment.
Astrana Health, Inc. COO and CFO Basho Chandan surrendered 3,870 shares of common stock at $29.07 per share on April 14, 2026 to cover tax withholding obligations on newly vested restricted stock. After this tax-withholding disposition, he directly holds 167,765 shares, including 30,404 unvested restricted shares and additional restricted stock units scheduled to vest through 2027.
Lam Thomas S. reported acquisition or exercise transactions in this Form 4 filing.
Astrana Health, Inc. director Thomas S. Lam received an equity award of 41,667 restricted stock units (RSUs) of common stock on April 6, 2026. The RSUs carry no purchase price and represent a compensation grant, not an open-market share purchase.
Each RSU is a contingent right to one Astrana common share. The award will vest in eight equal semi-annual installments beginning on October 6, 2026, provided Lam remains employed with Astrana Health and/or its affiliates. After this grant, he directly holds 465,657 shares of common stock, including other previously granted restricted stock and RSUs subject to multi-year vesting schedules.
Separate from his direct holdings, Lam is reported as having indirect interests in 6,132,802 shares held by Allied Physicians of California, a Professional Medical Corporation, where he serves as CEO, CFO, director and stockholder, and 1,133,706 shares held by the Thomas and Jeanette Lam 2002 Family Trust. He disclaims beneficial ownership of the Allied Physicians shares except to the extent of his pecuniary interest.
Sim Kenneth T. reported acquisition or exercise transactions in this Form 4 filing.
Astrana Health, Inc. Executive Chairman Kenneth T. Sim received a grant of 100,000 restricted stock units of common stock as compensation. Each unit represents one share and vests in eight equal semi-annual installments beginning on October 6, 2026, if he remains employed. After this award, he directly holds 739,407 common shares, including other unvested restricted stock and restricted stock units with vesting schedules extending into 2027. He also has additional indirect holdings through various trusts and entities where he disclaims full beneficial ownership.
Sim Brandon reported acquisition or exercise transactions in this Form 4 filing.
Astrana Health, Inc. CEO and President Brandon Sim reported an equity compensation grant in the form of 201,056 restricted stock units, each representing a right to receive one share of common stock. These units are scheduled to vest in eight equal semi-annual installments beginning on October 6, 2026, subject to continued employment. Following this grant, Sim directly holds 1,246,385 shares of common stock, including other unvested restricted stock and restricted stock units. The filing also notes indirect holdings in the Sim Family Irrevocable Trust 2021 and the Brandon Sim 2020 Irrevocable Trust, for which Sim disclaims beneficial ownership except for any pecuniary interest.
Astrana Health Chief Medical Officer Dinesh M. Kumar reported routine equity compensation activity. On April 1, 2026, he received 35,300 shares of common stock at no cost upon vesting of performance-based restricted stock units after performance exceeded target levels. On the same date, 57,980 shares were surrendered at $24.51 per share to cover tax withholding obligations tied to vesting restricted stock and restricted stock units, rather than being sold on the open market. After these transactions, he directly held 177,655 shares, including time-based restricted stock and restricted stock units scheduled to vest through January 2027 and in six semi-annual installments beginning September 5, 2026, as well as shares acquired under the employee stock purchase plan.
Astrana Health, Inc. COO and CFO Basho Chandan reported a small tax-related share disposition. On April 2, 2026, he surrendered 2,092 shares of common stock at an assigned price of $25.05 per share to cover tax withholding obligations tied to restricted stock units that vested that day.
After this tax-withholding transaction, Chandan directly holds 171,635 shares of Astrana Health common stock. This figure includes unvested restricted stock and restricted stock units scheduled to vest over the next several years, subject to his continued employment with the company.
Astrana Health, Inc. Chief Accounting Officer Glenn Sobotka reported a routine tax-withholding transaction involving company stock. On March 26, 2026, he surrendered 662 shares of common stock at $24.27 per share to cover taxes on restricted stock that vested that day. Following this non‑market disposition, he directly holds 14,039 shares, including unvested restricted stock awards. These include 4,824 shares scheduled to vest in three equal annual installments beginning on March 26, 2027, and 8,269 shares that will vest only if certain performance goals are achieved.
Astrana Health, Inc. director Thomas S. Lam reported a tax-related share disposition. On March 5, 2026, he surrendered 9,266 shares of common stock at $25.07 per share to cover tax withholding on vested restricted stock, leaving 423,990 shares held directly.
He also reports indirect ownership of 6,132,802 shares of common stock through Allied Physicians of California, a Professional Medical Corporation, and 1,133,706 shares through the Thomas and Jeanette Lam 2002 Family Trust. He disclaims beneficial ownership of the Allied Physicians shares except to the extent of his pecuniary interest.
His direct holdings include restricted stock that may vest later, with 51,667 shares scheduled to vest in two equal annual installments beginning on March 5, 2027, and 26,667 shares vesting upon achievement of pre-established performance goals.
Astrana Health, Inc. Chief Medical Officer Dinesh M. Kumar reported a tax-withholding disposition of company stock. On March 5, 2026, 1,697 shares of common stock were surrendered at $25.07 per share to cover tax obligations related to vested restricted stock units.
After this withholding transaction, Kumar directly held 200,335 shares of Astrana Health common stock. This total includes time-based and performance-based restricted stock and restricted stock units that will vest over future dates, as well as 1,405 shares previously acquired under the employee stock purchase plan.
Astrana Health, Inc. COO and CFO Basho Chandan reported a tax-related share surrender. On March 5, 2026, he disposed of 1,240 shares of common stock at $25.07 per share to cover withholding taxes tied to vesting restricted stock units. After this tax-withholding disposition, he directly owned 173,727 shares, which the footnotes state include both vested shares and multiple tranches of unvested restricted stock and restricted stock units scheduled to vest over 2026 and 2027, subject to continued employment.
Astrana Health, Inc. CEO and President Brandon Sim reported an option exercise converting 21,334 stock options into common shares at a price of $ 23.24 per share on 02/02/2026. Following this transaction, he directly owns 1,045,329 shares of Astrana Health common stock.
In addition to his direct holdings, 258,824 common shares are held by the Sim Family Irrevocable Trust 2021 and 392,816 shares are held by the Brandon Sim 2020 Irrevocable Trust, for which he disclaims beneficial ownership except to the extent of his pecuniary interest. His reported direct holdings also include unvested restricted stock and restricted stock units scheduled to vest between March 2026 and June 2026, subject to continued employment.
Astrana Health, Inc.’s Chief Medical Officer, Dr. Dinesh M. Kumar, reported a tax-related share surrender. On January 23, 2026, he surrendered 10,759 shares of Astrana Health common stock at $27.16 per share to cover withholding taxes on vested restricted stock.
After this transaction, Dr. Kumar beneficially owned 202,032 shares of common stock. This amount includes time-based and performance-based restricted stock and restricted stock units, as well as shares previously acquired under the company’s employee stock purchase plan, all of which vest over future dates subject to continued employment and performance conditions.
Astrana Health director David Schmidt reported exercising stock options and related share withholding. On January 13, 2026, he exercised 20,000 stock options with an exercise price of $5.79 per share, receiving the same number of Astrana Health common shares.
On the same date, 4,269 common shares were withheld at a price of $27.12 in a transaction coded "F," typically reflecting shares withheld to cover taxes. After these transactions, Schmidt directly owned 31,494 common shares, which include 6,449 shares of restricted stock scheduled to vest on the earlier of June 11, 2026 or the issuer's 2026 annual stockholder meeting. The exercised option position was reduced to 0 derivative securities.
Astrana Health (ASTH) Executive Chairman and Director Kenneth T. Sim reported an insider transaction. On 11/10/2025, he exercised stock options at $17.78 to acquire 29,502 shares of common stock (transaction code M), bringing his direct holdings to 639,407 shares. He also reports indirect holdings, including 6,132,802 shares by Allied Physicians of California, 546,349 by the Kenneth T & Simone S Sim Family Trust, 42,996 by the Kenneth T. Sim Pension Plan Trust, and 230,688 by a grantor retained annuity trust. Unvested restricted stock included in his holdings comprises 117,501 shares vesting in three equal annual installments beginning on March 5, 2026, and 133,333 shares vesting upon achievement of pre-established performance goals.
Astrana Health (ASTH): A company director exercised stock options and acquired 20,000 shares of common stock at $18.20 on 11/10/2025. Following the transaction, the director directly owns 34,763 shares. This total includes 6,449 restricted shares that will vest on the earlier of June 11, 2026 or the company’s 2026 annual meeting of stockholders. The exercised option covered 20,000 underlying shares and now shows a remaining balance of 0.
Astrana Health (ASTH) director reported insider transactions on 11/03/2025. The filing shows an option exercise for 20,000 shares at $18.20 per share (Code M), followed by share withholding for taxes of 11,033 shares at $32.99 (Code F).
Following these transactions, the director beneficially owns 92,608 shares directly, which includes 6,449 restricted shares that vest on the earlier of June 11, 2026 or the 2026 annual meeting. The exercised options were fully vested and exercisable.